This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Kato J-D, Wang CT.Cardiac rehabilitation participant with sickle cell trait and statin-related hepatotoxicity: A case report. Journal of Cardiopulmonary Rehabilitation and Prevention 32: 182-186, No. 4, Jul-Aug 2012. Available from: URL: http://dx.doi.org/10.1097/HCR.0b013e318255a382 - Canada
Additional information
Key words
adverse reactions; drug-induced; Atorvastatin; Rosuvastatin; Liver-injury
An event is serious (FDA MedWatch definition) when the patient outcome is: death; life-threatening; hospitalisation; disability; congenital anomaly; requires intervention to prevent permanent impairment or damage
Rights and permissions
About this article
Cite this article
Atorvastatin/rosuvastatin. React. Wkly. 1426, 12 (2012). https://doi.org/10.2165/00128415-201214260-00041
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201214260-00041